You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • FRI0008 Baseline Osteopontin Levels PREDICT the Clinical Efficacy of TOCILIZUMAB not Infliximab in Bio-Naive Rheumatoid Arthritis Patients: the Keio First BIO Cohort at 1 Year

Citation Tools

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Poster Presentations. Rheumatoid arthritis - prognosis, predictors and outcome
FRI0008 Baseline Osteopontin Levels PREDICT the Clinical Efficacy of TOCILIZUMAB not Infliximab in Bio-Naive Rheumatoid Arthritis Patients: the Keio First BIO Cohort at 1 Year

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Izumi K, Kaneko Y, Hashizume M, et al
FRI0008 Baseline Osteopontin Levels PREDICT the Clinical Efficacy of TOCILIZUMAB not Infliximab in Bio-Naive Rheumatoid Arthritis Patients: the Keio First BIO Cohort at 1 Year
Annals of the Rheumatic Diseases 2014;73:384.